Physician profile
Gregory J Kovacevich
NPI 1164498275
$10,069.51
in general payments reported to CMS, 2019-2025
20 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,426 · 2020: $189 · 2021: $96.20 · 2022: $138 · 2023: $45.66 · 2024: $1,829 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $534 · Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $533.59 |
| Food and Beverage | $187.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $7,453.44 | 2019-2023 | |
| Intuitive Surgical, INC. | $2,087.91 | 2024-2025 | |
| Lupin INC. | $73.15 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $63.10 | 2019-2020 | |
| Exeltis, USA INC. | $50.92 | 2020-2025 | Slynd |
| Coopersurgical, INC. | $48.97 | 2019-2022 | |
| Astellas Pharma US INC | $36.00 | 2024-2025 | Veozah |
| Myovant Sciences INC. | $31.42 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $29.76 | 2023 | Myfembree |
| Aspira Women'S Health INC | $25.96 | 2022 | |
| Mayne Pharma Commercial LLC | $23.99 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.47 | 2019 | |
| Amag Pharmaceuticals, INC. | $20.57 | 2019 | |
| Merck Sharp & Dohme LLC | $19.09 | 2021 | |
| Hologic Sales and Service, LLC | $17.49 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $16.84 | 2021 | |
| Roche Diagnostics Corporation | $16.20 | 2019 | |
| Evofem Biosciences, INC. | $13.99 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.49 | 2021 | |
| Meditrina | $4.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kovacevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.